Brussels, 21/11/2005 (Agence Europe) - In a press release published on 17 November, the European Agency for the Evaluation of Medicinal Products (EMEA) reconsiders the harmlessness of the antiviral drug Oseltamivir, which is sold by the Swiss laboratory Roche under the name Tamiflu. Whilst indicating its awareness of two cases of death by suicide associated with the taking of this drug (a 17 year old adolescent in February 2004 and a 14-year-old boy in February 2005), the Agency attempted to...